Search results
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 3 days agoThe vaccine's efficacy is reported at 79% on the label, slightly lower than the 84% previously...
Comparable rate of firearm deaths among rural, urban Black youth
MinnPost· 6 days agoWhen University of Minnesota graduate student Allison Lind, in her work with runaway youth, began...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 6 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today ...